Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Global Serotonin Supplement Market is valued at approximately USD 945.23 million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.58% over the forecast period 2024-2032.

All eligible U.S. states and territories have agreed to sign a $7.4 billion settlement with the company and family behind OxyContin, officials announced Monday.

Eli Lilly ( LLY 0.82%) has been a great growth pick for investors over the past few years. The pharma company, thanks to its ...

The decision to advance the trials is based on feedback received from regulatory authorities in interactions following the ...

Wednesday marked a losing session on Wall Street, with the S&P 500 snapping its three-day win streak, as did the Nasdaq ...

The president promised lower prices on medications for Americans, but the state’s independent pharmacies doubt that will ...

The U.S. FDA ordered a pause on clinical trials of a combination therapy for HIV. This won't affect the company's other HIV ...

After a quiet coaching carousel this past offseason, Joel Klatt shared which 10 coaches are under the most pressure heading ...

Apple investors waiting for the company to make a big push in artificial intelligence didn’t have much reason for excitement at WWDC.